Molecular subtyping and precision medicine for pancreatic cancer

Froeling, F. E.M. , Casolino, R., Pea, A., Biankin, A. V. and Chang, D. K. (2021) Molecular subtyping and precision medicine for pancreatic cancer. Journal of Clinical Medicine, 10(1), 149. (doi: 10.3390/jcm10010149) (PMID:33406790) (PMCID:PMC7794969)

[img] Text
235172.pdf - Published Version
Available under License Creative Commons Attribution.



Substantial progress in recent years has dramatically increased our knowledge of the molecular basis of cancer, revealing new potential therapeutic targets and paving the way for effective personalised medicine for the treatment of many tumour types. However, pancreatic cancer has been lagging behind in this success and continues to be one of the most lethal solid malignancies. Its molecular heterogeneity and the unselected design of the majority of clinical trials to date can in part explain the reason for our failure to make a significant change in the survival outcomes for patients with pancreatic cancer. A changing paradigm in drug development is required to validate the new molecular taxonomy and to rapidly translate preclinical discovery into clinical trials. Here, we review the molecular subtyping of pancreatic cancer, the challenges in identifying effective treatment regimens according to defined low-prevalence molecular subgroups and we illustrate a new model of translational therapeutic development that was established in the U.K. (Precision-Panc) as a potentially effective solution to improve outcomes for patients with pancreatic cancer.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Biankin, Professor Andrew and pea, Dr Antonio and Casolino, Dr Raffaella and Froeling, Dr Fieke and Chang, Professor David
Authors: Froeling, F. E.M., Casolino, R., Pea, A., Biankin, A. V., and Chang, D. K.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Journal of Clinical Medicine
ISSN (Online):2077-0383
Published Online:04 January 2021
Copyright Holders:Copyright © 2021 by the authors
First Published:First published in Journal of Clinical Medicine 10(1):149
Publisher Policy:Reproduced under a Creative Commons license

University Staff: Request a correction | Enlighten Editors: Update this record